Has Steven Abman received payments from drug or device companies?

Yes. Drug and device makers reported $86,738 in general payments to Steven Abman across 54 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Steven Abman did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Steven Abman come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Steven Abman

Pediatric Pulmonology · Aurora, CONPI 1841375573

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $60,023 of the $86,738 with a category attached, or 69.2%. 11 manufacturers reported payments, led by Shire North American Group Inc at 34.6% of the total. Reporting peaked in 2019 at $46,393 and has fallen 87.4% since, to $5,831 in 2025. Among pediatric pulmonology clinicians in CO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$86,738in general payments, 2019–2025

Across 54 payments — averaging $1606.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Shire North American Group Inc$30K
Mallinckrodt Hospital Products Inc.$17K
Actelion Pharmaceuticals, Ltd$15K
Chiesi USA, Inc.$12K
Upjohn US 1 LLC$5K
Merck$4K
plus $3K from 5 others

$249,486in research payments, 2019–2025

Across 5 payments — averaging $49,897 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

United Therapeutics Corporation$247K
Bayer$3K

What the payments were for

Consulting fees$60,02369%
Speaking & faculty fees$5,1806%
Travel & lodging$20,29823%
Food & beverage$1,1781%
Education$590%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Shire North American Group Inc	17	$29,982
Mallinckrodt Hospital Products Inc.	3	$17,272
Actelion Pharmaceuticals, Ltd	10	$14,971
Chiesi USA, Inc.	12	$11,992
Upjohn US 1 LLC	1	$5,180
Merck	2	$3,985
Bayer	1	$1,320
Pfizer	4	$1,266
ZOLL Medical Corporation	2	$625
Mallinckrodt Enterprises LLC	1	$120
Boston Scientific	1	$26

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

INOMAX$17,313
OPSUMIT$3,300
Adempas$1,320
REVATIO$1,266

How this compares

$86,738 in reported general payments places this provider in the 90th percentile of 29 pediatric pulmonology providers in Colorado.

See all pediatric pulmonology providers in Colorado →

Other pediatric pulmonology in Aurora

Stanley SzeflerAurora$114K
Robin DeterdingAurora$108K
Emily DeboerAurora$73K
Edith ZemanickAurora$15K
Oren KupferAurora$11K
Jordana HoppeAurora$7K
Ann HalbowerAurora$6K
Scott SagelAurora$4K
Stacey MartinianoAurora$1K
Christopher BakerAurora$753

See the full list for Colorado →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →